Epigenetic regulation of the cell type-specific gene 14-3-3σ

Marc M. Oshiro, Bernard W Futscher, Aaron Lisberg, Ryan J. Wozniak, Walter Klimecki, Frederick E. Domann, Anne E Cress

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Epigenetic control participates in processes crucial in mammalian development, such as X-chromosome inactivation, gene imprinting, and cell type-specific gene expression. We provide evidence that the p53-inducible gene 14-3-3σ is a new example of a gene important to human cancer, where epigenetic mechanisms participate in the control of normal cell type-specific expression, as well as aberrant gene silencing in cancer cells. Like a previously identified cell type-specific gene maspin, 14-3-3σ is a p53-inducible gene; however, it participates in G2/M arrest in response to DNA-damaging agents. 14-3-3σ expression is restricted to certain epithelial cell types, including breast and prostate, whereas expression is absent in nonepithelial tissues such as fibroblasts and lymphocytes. In this report, we show that in normal cells expressing 14-3-3σ, the , 14-3-3σ CpG island is unmethylated; associated with acetylated histones, unmethylated histone H3 lysine 9; and an accessible chromatin structure. By contrast, normal cells that do not express 14-3-3σ have a methylated 14-3-3σ CpG island with hypoacetylated histones, methylated histone H3 lysine 9, and an inaccessible chromatin structure. These findings extend the spectrum of cell type-specific genes controlled partly by normal epigenetic mechanisms, and suggest that this subset of genes may represent important targets of epigenetic dysregulation in human cancer.

Original languageEnglish (US)
Pages (from-to)799-808
Number of pages10
JournalNeoplasia
Volume7
Issue number9
DOIs
StatePublished - Sep 2005

Fingerprint

Epigenomics
Histones
Genes
CpG Islands
p53 Genes
Lysine
Chromatin
X Chromosome Inactivation
Neoplasms
X-Linked Genes
Gene Silencing
Prostate
Breast
Fibroblasts
Epithelial Cells
Lymphocytes
Gene Expression
DNA

Keywords

  • 14-3-3σ
  • Chromatin
  • Histone
  • Histone acetylation
  • Methylation

ASJC Scopus subject areas

  • Cancer Research

Cite this

Epigenetic regulation of the cell type-specific gene 14-3-3σ. / Oshiro, Marc M.; Futscher, Bernard W; Lisberg, Aaron; Wozniak, Ryan J.; Klimecki, Walter; Domann, Frederick E.; Cress, Anne E.

In: Neoplasia, Vol. 7, No. 9, 09.2005, p. 799-808.

Research output: Contribution to journalArticle

Oshiro, Marc M. ; Futscher, Bernard W ; Lisberg, Aaron ; Wozniak, Ryan J. ; Klimecki, Walter ; Domann, Frederick E. ; Cress, Anne E. / Epigenetic regulation of the cell type-specific gene 14-3-3σ. In: Neoplasia. 2005 ; Vol. 7, No. 9. pp. 799-808.
@article{2edf2d974a5b4573b0e6d88608b51a9d,
title = "Epigenetic regulation of the cell type-specific gene 14-3-3σ",
abstract = "Epigenetic control participates in processes crucial in mammalian development, such as X-chromosome inactivation, gene imprinting, and cell type-specific gene expression. We provide evidence that the p53-inducible gene 14-3-3σ is a new example of a gene important to human cancer, where epigenetic mechanisms participate in the control of normal cell type-specific expression, as well as aberrant gene silencing in cancer cells. Like a previously identified cell type-specific gene maspin, 14-3-3σ is a p53-inducible gene; however, it participates in G2/M arrest in response to DNA-damaging agents. 14-3-3σ expression is restricted to certain epithelial cell types, including breast and prostate, whereas expression is absent in nonepithelial tissues such as fibroblasts and lymphocytes. In this report, we show that in normal cells expressing 14-3-3σ, the , 14-3-3σ CpG island is unmethylated; associated with acetylated histones, unmethylated histone H3 lysine 9; and an accessible chromatin structure. By contrast, normal cells that do not express 14-3-3σ have a methylated 14-3-3σ CpG island with hypoacetylated histones, methylated histone H3 lysine 9, and an inaccessible chromatin structure. These findings extend the spectrum of cell type-specific genes controlled partly by normal epigenetic mechanisms, and suggest that this subset of genes may represent important targets of epigenetic dysregulation in human cancer.",
keywords = "14-3-3σ, Chromatin, Histone, Histone acetylation, Methylation",
author = "Oshiro, {Marc M.} and Futscher, {Bernard W} and Aaron Lisberg and Wozniak, {Ryan J.} and Walter Klimecki and Domann, {Frederick E.} and Cress, {Anne E}",
year = "2005",
month = "9",
doi = "10.1593/neo.05274",
language = "English (US)",
volume = "7",
pages = "799--808",
journal = "Neoplasia",
issn = "1522-8002",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Epigenetic regulation of the cell type-specific gene 14-3-3σ

AU - Oshiro, Marc M.

AU - Futscher, Bernard W

AU - Lisberg, Aaron

AU - Wozniak, Ryan J.

AU - Klimecki, Walter

AU - Domann, Frederick E.

AU - Cress, Anne E

PY - 2005/9

Y1 - 2005/9

N2 - Epigenetic control participates in processes crucial in mammalian development, such as X-chromosome inactivation, gene imprinting, and cell type-specific gene expression. We provide evidence that the p53-inducible gene 14-3-3σ is a new example of a gene important to human cancer, where epigenetic mechanisms participate in the control of normal cell type-specific expression, as well as aberrant gene silencing in cancer cells. Like a previously identified cell type-specific gene maspin, 14-3-3σ is a p53-inducible gene; however, it participates in G2/M arrest in response to DNA-damaging agents. 14-3-3σ expression is restricted to certain epithelial cell types, including breast and prostate, whereas expression is absent in nonepithelial tissues such as fibroblasts and lymphocytes. In this report, we show that in normal cells expressing 14-3-3σ, the , 14-3-3σ CpG island is unmethylated; associated with acetylated histones, unmethylated histone H3 lysine 9; and an accessible chromatin structure. By contrast, normal cells that do not express 14-3-3σ have a methylated 14-3-3σ CpG island with hypoacetylated histones, methylated histone H3 lysine 9, and an inaccessible chromatin structure. These findings extend the spectrum of cell type-specific genes controlled partly by normal epigenetic mechanisms, and suggest that this subset of genes may represent important targets of epigenetic dysregulation in human cancer.

AB - Epigenetic control participates in processes crucial in mammalian development, such as X-chromosome inactivation, gene imprinting, and cell type-specific gene expression. We provide evidence that the p53-inducible gene 14-3-3σ is a new example of a gene important to human cancer, where epigenetic mechanisms participate in the control of normal cell type-specific expression, as well as aberrant gene silencing in cancer cells. Like a previously identified cell type-specific gene maspin, 14-3-3σ is a p53-inducible gene; however, it participates in G2/M arrest in response to DNA-damaging agents. 14-3-3σ expression is restricted to certain epithelial cell types, including breast and prostate, whereas expression is absent in nonepithelial tissues such as fibroblasts and lymphocytes. In this report, we show that in normal cells expressing 14-3-3σ, the , 14-3-3σ CpG island is unmethylated; associated with acetylated histones, unmethylated histone H3 lysine 9; and an accessible chromatin structure. By contrast, normal cells that do not express 14-3-3σ have a methylated 14-3-3σ CpG island with hypoacetylated histones, methylated histone H3 lysine 9, and an inaccessible chromatin structure. These findings extend the spectrum of cell type-specific genes controlled partly by normal epigenetic mechanisms, and suggest that this subset of genes may represent important targets of epigenetic dysregulation in human cancer.

KW - 14-3-3σ

KW - Chromatin

KW - Histone

KW - Histone acetylation

KW - Methylation

UR - http://www.scopus.com/inward/record.url?scp=33644875123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644875123&partnerID=8YFLogxK

U2 - 10.1593/neo.05274

DO - 10.1593/neo.05274

M3 - Article

C2 - 16229802

AN - SCOPUS:33644875123

VL - 7

SP - 799

EP - 808

JO - Neoplasia

JF - Neoplasia

SN - 1522-8002

IS - 9

ER -